While robotic platforms are increasingly used in metabolic surgery, clinical outcomes of sympathectomy (surgical or endovascular) have shown promising effects in controlling glucose, insulin sensitivity and in reducing sympathetic overactivity in patients with T2DM or metabolic syndrome (13, 15). Here, INS is linked to type 2 diabetes mellitus.